Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Alcobra Ltd announces shares uplisted to NASDAQ Global Market


Wednesday, 26 Mar 2014 08:00am EDT 

Alcobra Ltd:Approves to list on Nasdaq Global Market, effective with open of stock market on March 28.Until stock is transferred to NASDAQ Global Market, ADHD's stock will continue to trade on Nasdaq Capital Market.Company will continue to trade under its existing ticker symbol 'ADHD. 

Company Quote

4.0
0.24 +6.38%
24 Dec 2014